| Pfizer Inc (PFE) | |||
|---|---|---|---|
| 37.23 0.7 (1.92%) | 11-27 13:02 | ||
| Open: | 36.78 | Pre. Close: | 36.53 |
| High: | 37.26 | Low: | 36.75 |
| Volume: | 25,080,500 | Market Cap: | 206,939M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 36.645 - 36.826 | 36.826 - 36.972 |
| Low: | 35.733 - 35.982 | 35.982 - 36.185 |
| Close: | 36.182 - 36.558 | 36.558 - 36.864 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 46.53 One year: 54.35 |
| Support: | Support1: 35.51 Support2: 32.83 |
| Resistance: | Resistance1: 39.84 Resistance2: 46.53 |
| Pivot: | 36.32 |
| Moving Averages: | MA(5): 36.72 MA(20): 35.85 MA(100): 35.34 MA(250): 34.74 |
| MACD: | MACD(12,26): 0.46 Signal(12,26,9): 0.36 |
| %K %D: | %K(14,3): 45.48 %D(3): 43.55 |
| RSI: | RSI(14): 60.05 |
| 52-Week: | High: 39.83871 Low: 26.451612 Change(%): 2.5 |
| Average Vol(K): | 3-Month: 3369095 10-Days: 4634631 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.PFE has closed below upper band by 16.0%. Bollinger Bands are 7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Growth | |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency |  |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers General | |
| Shares Out. (M) | 5560.00 |
| Shares Float (M) | 5550.00 |
| % Held by Insiders | 0.05 |
| % Held by Institutions | 70.75 |
| Shares Short (K) | 45930 |
| Shares Short Prior Month (K) | 45160 |
| Stock Financials | |
|---|---|
| EPS | 1.540 |
| Book Value (p.s.) | 11.740 |
| Profit Margin | 17.85 |
| Operating Margin | 29.24 |
| Return on Assets (ttm) | 5.1 |
| Return on Equity (ttm) | 13.3 |
| Qtrly Rev. Growth | -4.3 |
| Gross Profit (p.s.) | 7.507 |
| Sales Per Share | 8.750 |
| EBITDA (p.s.) | 3.475 |
| Qtrly Earnings Growth | -71.40 |
| Operating Cash Flow (M) | 12550.00 |
| Levered Free Cash Flow (M) | -655.25 |
| Stock Valuation | |
|---|---|
| PE Ratio | 24.18 |
| PEG Ratio | 2.34 |
| Price to Book value | 3.17 |
| Price to Sales | 4.25 |
| Price to Cash Flow | 16.49 |
| Stock Dividends | |
|---|---|
| Dividend | 1.500 |
| Dividend Yield | 0.04 |
| Dividend Growth | 1.520 |
